F · Healthcare
Drug Manufacturers - Specialty & Generic
SHANG.FOS.PHARM.GR.H YC 1 (08HH) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported market cap is $5.05B, P/E ratio is 11.13, net margin is 8.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
SHANG.FOS.PHARM.GR.H YC 1 (08HH) has a reported market cap of $5.05B (data as of 2026-05-24).
The price-to-earnings (P/E) ratio for SHANG.FOS.PHARM.GR.H YC 1 (08HH) is 11.13 (data as of 2026-05-24).
Dividend yield is not available in the current snapshot for SHANG.FOS.PHARM.GR.H YC 1 (08HH). Check the MyAverix Finance app for the latest dividend data.
SHANG.FOS.PHARM.GR.H YC 1 (08HH) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
08HH is listed on F.
SHANG.FOS.PHARM.GR.H YC 1 (08HH) reports a net margin of 8.2% (data as of 2026-05-24).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.